Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations. ECN members are chosen by the Board of Directors.
![Vasant (Vas) Narasimhan, M.D., Chief Executive Officer Vasant (Vas) Narasimhan, M.D., Chief Executive Officer](/sites/novartis_com/files/styles/biography_image/public/2021-08/vas-narasimhan-big.jpg.webp?itok=slK4prq-)
![Shreeram Aradhye, President, Development and Chief Medical Officer Shreeram Aradhye, President, Development and Chief Medical Officer](/sites/novartis_com/files/styles/biography_image/public/2022-07/shreeram-aradhye-big.jpg.webp?itok=ne10vaiK)
![Victor Bulto, President, US Victor Bulto, President, US](/sites/novartis_com/files/styles/biography_image/public/2022-04/victor-bulto.jpg.webp?itok=2MNDsmsa)
![Aharon (Ronny) Gal, PhD, Chief Strategy & Growth Officer Aharon (Ronny) Gal, PhD, Chief Strategy & Growth Officer](/sites/novartis_com/files/styles/biography_image/public/2022-09/aharon-ronny-gal-portrait.jpg.webp?itok=ULPZOb7c)
![Karen L. Hale, Chief Legal Officer Karen L. Hale, Chief Legal Officer](/sites/novartis_com/files/styles/biography_image/public/2021-07/karen-hale-big-1-image.jpg.webp?itok=nixH0jdI)
![Dr. Patrick Horber, President, International, since December 1, 2023 Dr. Patrick Horber, President, International, since December 1, 2023](/sites/novartis_com/files/styles/biography_image/public/2023-11/patrick-horber.jpg.webp?itok=iIV71MN7)
![Harry Kirsch, Chief Financial Officer Harry Kirsch, Chief Financial Officer](/sites/novartis_com/files/styles/biography_image/public/2021-08/harry-kirsch-big.jpg.webp?itok=LKPAnypG)
![Rob Kowalski, Chief People & Organization Officer Rob Kowalski, Chief People & Organization Officer](/sites/novartis_com/files/styles/biography_image/public/2021-10/rob-kowalski-big.jpg.webp?itok=EwO41C0R)
![Steffen Lang, Ph.D., President, Operations Steffen Lang, Ph.D., President, Operations](/sites/novartis_com/files/styles/biography_image/public/2021-08/steffen-lang-big.jpg.webp?itok=sD9CooXt)
![Fiona H. Marshall, Ph.D., President, Biomedical Research Fiona H. Marshall, Ph.D., President, Biomedical Research](/sites/novartis_com/files/styles/biography_image/public/2022-10/fiona-marshall-portrait-big.jpg.webp?itok=uij2ejf1)
![Klaus Moosmayer, Ph.D., Chief Ethics, Risk and Compliance Officer Klaus Moosmayer, Ph.D., Chief Ethics, Risk and Compliance Officer](/sites/novartis_com/files/styles/biography_image/public/2021-08/moosmayer-klaus-big.jpg.webp?itok=deeo4bbJ)
Other Members of Senior Management
![Lutz Hegemann, M.D., Ph.D., President, Global Health & Sustainability Lutz Hegemann, M.D., Ph.D., President, Global Health & Sustainability](/sites/novartis_com/files/styles/biography_image/public/2021-08/lutz-hegemann.jpg.webp?itok=_GL_6nkM)
![Kees Roks, Chief Audit Officer Kees Roks, Chief Audit Officer](/sites/novartis_com/files/styles/biography_image/public/2022-05/kees-roks-portrait-big.jpg.webp?itok=Z1B-zG89)
![Michelle Weese, Chief Corporate Affairs Officer Michelle Weese, Chief Corporate Affairs Officer](/sites/novartis_com/files/styles/biography_image/public/2023-11/michelle-weese-1.jpg.webp?itok=-vN7xs-d)
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations. ECN members are chosen by the Board of Directors.